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Abstract
Background: Expression of the tumor suppressor p16
INK4a increases during aging and replicative senescence.
Methodology/Principal Findings: Here, we report that the microRNA miR-24 suppresses p16 expression in human diploid
fibroblasts and cervical carcinoma cells. Increased p16 expression with replicative senescence was associated with
decreased levels of miR-24, a microRNA that was predicted to associate with the p16 mRNA coding and 39-untranslated
regions. Ectopic miR-24 overexpression reduced p16 protein but not p16 mRNA levels. Conversely, introduction of antisense
(AS)-miR-24 blocked miR-24 expression and markedly enhanced p16 protein levels, p16 translation, and the production of
EGFP-p16 reporter bearing the miR-24 target recognition sites.
Conclusions/Significance: Together, our results suggest that miR-24 represses the initiation and elongation phases of p16
translation.
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Introduction
In mammalian systems, the maintenance of homeostasis requires
a tight control of cell proliferation. p16
INK4a (hereafter p16) inhibits
the cyclin-dependent kinases CDK4 and CDK6, thereby keeping
the retinoblastoma protein (pRB) in a hypophosphorylated state and
arresting cells in the G1 phase of the division cycle [1]. Loss or
inactivation of the INK4a/ARF locus (harboring p16 and ARF) are
among the most frequent alterations seen in human cancers,
underscoring the widely recognized role of p16 as a tumor
suppressor [2,3]. In addition, p16 critically influences the process
of replicative senescence, whereby cells reach a state in which they
remain metabolically active but appear incapable of further division.
Cellular senescence is triggered by stimuli such as aberrant
proliferative signals or damage to DNA or other macromolecules
[4, 5]. In agreement with earlier observations that p16 levels
increased with aging [6–8], and that p16 overexpression triggers a
senescent phenotype [9] recent discoveries support the notion that
cellular senescence playsa direct roleinmammalian aging. In mouse
models, p16 deficiency partially prevented the age-induced decline
in cell proliferation and tissue function [10].
Given the prominent role of p16 in cancer and senescence/
aging, there is much interest in understanding the molecular
regulators of p16 expression as triggered by both environmental
signals and developmental cues. Transcriptionally, CDC6 was
reported to silence the INK4a/ARF locus by heterochromatiniza-
tion linked to DNA replication [11]. In addition, p16 expression
was shown to be induced by transcription factors such as Ets1,
Ets2, and JunB [12,13] and repressed by transcription factors such
as Id1 and Id3 [13,14] and by Bmi-1 [15]. Posttranscriptionally,
the splicing of p16 mRNA was proposed to be influenced by ASF/
SF2 and the p16 mRNA stability reduced by RNA-binding
proteins (RBPs) hnRNP A1, hnRNP A2, and AUF1 [16,17].
RBPs constitute a major class of major trans acting factors that
associate with RNAs and regulate gene expression after transcrip-
tion by influencing processes such as pre-mRNA splicing and
maturation, and mRNA transport, storage, stability, and transla-
tion [18]. The other major group of trans acting, posttranscrip-
tional regulatory factors are microRNAs (miRNAs), a collection of
short (,21–26-nt long), single-strand, noncoding RNAs that have
been described in a wide variety of organisms. The molecular
details of miRNA-mediated suppression of gene expression
(silencing) are rapidly emerging. miRNAs are assembled into
RNA-induced silencing complexes (RISC), which recruit a target
mRNA to processing bodies (P-bodies) that function as cytoplas-
mic foci of mRNA degradation and translational repression
(reviewed in reference [19]). Depending upon the degree of
complementarity of the mRNA-miRNA complex, miRNAs can
promote the cleavage of the target mRNA, an occurrence that is
favored by extensive complementarity with the mRNA, or they
can suppress mRNA translation but not mRNA degradation in
instances of less complete base-pairing [20–22]. However, the
precise mechanisms by which miRNAs inhibit translation remains
controversial. Some studies indicate that miRNAs block the
initiation of translation, in some instances triggering the formation
of large ribonucleoprotein (RNP) ‘pseudo-polysomes’, yet others
PLoS ONE | www.plosone.org 1 March 2008 | Volume 3 | Issue 3 | e1864suggest that miRNAs suppress post-initiation steps by repressing
translational elongation, by promoting ribosome drop-off or by
inhibiting termination [23–26]. It is likely that multiple mechanisms
are operating that depend on the nature of the miRNA, the
untranslated regions, and the cellular context. An integrated model
of miRNA action was proposed whereby miRNA action involved
both translational suppression and accelerated decay [19].
Here, we have identified miR-24-2 (hereafter miR-24) as a
microRNA that suppresses p16 translation in cultured human
cells. Modulation of miR-24 levels by transfection of either pre-
miR-24 or antisense (AS)-miR-24 directly affected p16 expression
levels by altering the engagement of p16 mRNA with the
translation machinery and consequently p16 biosynthesis. Our
results are consistent with a role for miR-24 in repressing both the
initiation and elongation stages of p16 translation.
Results and Discussion
Concomitantly Elevated p16 and Reduced miR-24 Levels
in Senescent WI-38 HDFs
p16 protein and mRNA levels increased markedly as early-
passage, proliferating (young, Y) WI-38 human diploid fibroblasts
(HDFs) progressed towards senescence (S) by increasing population
doublings (pdls) in culture (Fig. 1A,B). Since senescent cells showed
a lesser increase in p16 mRNA abundance (.7-fold) than in p16
protein levels (,40-fold), as previously observed [27], we
hypothesized that p16 protein translation might be selectively
favored with senescence. To test this possibility, cytoplasmic lysates
prepared from Y or S WI-38 cells were centrifuged through
sucrose density gradients in order to fractionate the translation
machinery components according to their molecular weight. By
this process, the lightest cytoplasmic components, which are not
engaged in translation (mRNA not bound to ribosomes, and 40S
and 60S ribosome subunits), appear at the top of the gradient
(fractions 1–4: NB/NT, not bound/not translated); heavier compo-
nents, comprising mRNAs bound to one or several ribosomes,
appear next, in the low molecular weight (LMW) polysome
fractions (fractions 5–7); and cosedimenting lower in the gradient
(fractions 8–10) are the mRNAs considered to be most actively
translated since they form part of high molecular weight (HMW)
polysomes. The distribution of p16 mRNA (and that of the
housekeeping GAPDH mRNA) was compared between Y (pdl 20)
and S (pdl 54) cells. Unexpectedly, despite the low p16 protein
levels in Y cells (Fig. 1A), most of the p16 mRNA was present in
the LMW and HMW polysome fractions, as was seen in S cells
(Fig. 1C), although the absolute p16 mRNA levels on the gradient
were significantly lower in Y cells (Fig. 1C, left, inset). This
observation suggested that in Y cells, while p16 mRNA associated
extensively with the translational machinery, it was not actively
translated, possibly through an inhibition of translational elongation.
In addition, we noted a small but consistent shift in the p16
mRNA of Y cells towards LMW polysomes, further indicating that
translational initiation may also be diminished. Together, these
observations suggest that p16 translation could be inhibited in Y
WI-38 cells, likely through a combination of decreased translation
initiation and elongation.
To test these possibilities, we examined whether RBPs
implicated in translational control (like TIAR, TIA-1 or elav/
Hu RBPs) bound the p16 mRNA, but no such pdl-dependent
RNP interactions were observed (not shown). Therefore, we
hypothesized that the translation of p16 mRNA might be
influenced by its association with microRNAs. RNA was prepared
from Y and S and used for miRNA microarray analysis (Exiqon,
Materials and Methods); the complete array report is available
from the authors. As shown (Fig. 2A), thirty-one miRNAs were
found to be lower in S populations. Importantly, all of the
miRNAs for which we were able to amplify PCR products (ten in
total) were found to be downregulated in S cells, supporting the
accuracy of the microarray analysis (Fig. 2B). The microRNA
miR-24 was predicted to bind to the p16 mRNA both in the
coding region (CR) and the 39-untranslated region (UTR) (Fig. 3A),
based on analysis using the Miranda and RNA22 programs ([28]
Supplemental Fig. S1). Miranda also predicted miR-337 to
associate with p16 mRNA, but miR-337 levels were not found
to be altered during senescence (Fig. 2A). An additional nine
miRNAs that were more highly expressed in S cells (Supplemental
Fig. S2) will be investigated separately.
We thus set out to investigate whether miR-24 might contribute
to regulating p16 expression during replicative senescence. Using
miR-24-specific primer pairs and reverse transcription (RT)
followed by real-time quantitative (q) PCR analysis, we first
measured the levels of mature miR-24 (Materials and Methods) in
Y and S populations (Fig. 3A, graph). On sucrose gradients, miR-
24 was found to be vastly more abundant [.70% in both Y (pdl
20) and S (pdl 54) HDFs] in fractions 1 and 2, and hence
dissociated from any ribosome components (Fig. 3B). However,
Figure 1. p16 levels increase with replicative senescence. (A)
The levels of mRNAs encoding cyclin D1, p16, and control housekeep-
ing GAPDH were measured by RT-qPCR, normalized to 18S rRNA levels
and plotted as fold levels relative to the levels in pdl 20 HDFs. (B)
Western blot analysis of p16 and loading control b-Actin levels in young
(Y, pdl 20) and senescent (S, pdl 54) WI-38 HDFs. (C) The polysomal
association of mRNAs encoding p16 (left) or GAPDH (right) in Y and S
WI-38 cells was tested by fractionating cytoplasmic lysates through
sucrose gradients and measuring mRNA abundance by RT-qPCR in each
of the 10 resulting fractions (insets). The relative abundance of p16 and
GAPDH mRNAs in each gradient fraction is shown as a percent of the
total mRNA. NB/NT (‘not bound/not translated’) fractions with mRNA
devoid of translational components; LMW, HMW,l o wa n dh i g h
molecular weight polysome fractions, respectively.
doi:10.1371/journal.pone.0001864.g001
miR-24 Blocks p16 Translation
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appear to associate with actively translating mRNAs, since
treatment with puromycin (Puro.) shifted the miR-24 distribution
towards lower molecular weight fractions relative to untreated
(Untr.) cells, particularly in Y populations (Fig. 3B). A direct
comparison of miR-24 levels in each gradient fraction showed that
in Y cells, miR-24 was relatively more abundant in the heavy
fractions and less in the light fractions, while in S cells, miR-24
levels were relatively higher in the light fractions and lower in the
heavy, polysome-associated fractions (Fig. 3C). This differential
distribution of miR-24 further supported the view that miR-24
might contribute to an inhibition of p16 translation in Y cells that
was relieved in S cells.
miR-24 Influences p16 Expression in Young and
Senescent WI-38 HDFs
Next, we investigated if miR-24 directly regulated p16 protein
abundance in WI-38 HDFs. The expression levels of miR-24 in
WI-38 cells were modulated in both directions, elevated by using a
pre-miR-24 RNA, reduced by using an antisense (AS)-miR-24
RNA. Pre-miR-24 was first introduced into late-passage cells
(,pdl 51) in order to ectopically elevate the levels of miR-24,
which are naturally low in cells of advanced pdls (Fig. 3A). Despite
the pre-senescent phenotype of these cells and their high p16
levels, miR-24 overexpression (Fig. 4A, right) markedly reduced
p16 protein abundance (Fig. 4B), but not p16 mRNA levels
(Fig. 4A, left). Conversely, Y HDFs were transfected with AS-miR-
24 in order to reduce the function of miR-24 in these populations
with high endogenous miR-24 levels (Fig. 3A). The intervention to
reduce miR-24 (Fig. 4C, right) caused no significant changes in p16
mRNA levels (Fig. 4C, left), but it strongly increased p16 protein
abundance (Fig. 4D). Transfection of AS-miR-24 caused a small
Figure 2. Microarray analysis of miRNAs showing reduced
expression with senescence. (A) Three independent preparations of
total RNA from early-passage (Young, pdl 25) and from late-passage
(Senescent, pdl 54) WI-38 cells were subjected to microarray analysis
(Exiqon, Materials and Methods). Thirty-one miRNAs showed reduced
levels in the senescent cultures (by two-fold in at least two samples), 9
miRNAs showed increased levels (Supplemental Fig. S2). (B) The
differential expression of ten downregulated miRNAs was validated
using RT-qPCR analysis; the relative levels of each miRNA in Y and S WI-
38 cells are shown (means+SEM from three independent experiments).
doi:10.1371/journal.pone.0001864.g002
Figure 3. miR-24 levels decrease with replicative senescence. (A)
Top, p16 mRNA depicting the two locations (in CR and 39UTR) where miR-
24 is predicted to bind. Bottom left,m i R - 2 4l e v e l sw e r em e a s u r e di nW I - 3 8
cells by RT-qPCR using miR-24-specific primers, and normalized to 5S
rRNA levels. Bottom right, PCR-amplified products (,100-bp), visualized
on 1.5% agarose gels, were absent from RT- reactions; MWM,D N A
molecular weight markers. (B) Young (pdl 20) or Senescent (pdl 54) WI-38
cells were left utnreated (Untr.) or treated with puromycin (Puro., 200 mM,
1 hr) and cytoplasmic lysates were prepared and fractionated through
sucrose gradients. The presence of miR-24 was measured in each fraction,
calculated as a percentage of the total miR-24, and plotted using a
semilogarithmic scale. The data are representative of 3 independent
experiments. (C) The relative abundance (fold) of miR-24 in each fraction
was compared between Y and S cells. In fractions 1–5 (black bars), miR-24
was comparable or more abundant in S than in Y cells; in fractions 6–10
(gray bars), miR-24 was more abundant in Y than in S cells. All bars
represent the means+SD from 3 independent experiments.
doi:10.1371/journal.pone.0001864.g003
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sucrose gradients (Fig. 4E). Nonetheless, this shift occurs in the
polysomal compartment (not in ligher fractons of the gradient), in
agreement with the view that the translational elongation of p16
mRNA may be enhanced in the AS-miR-24 transfection group.
Accordingly, the data could be interpreted as evidence that miR-
24 exerts pressure on translating ribosomes to abort translation
and ‘drop-off’, as suggested by Petersen and co-workers [24].
Together, these results support the view that the miR-24-elicited
suppression of p16 translation is relieved as miR-24 levels are
diminished in WI-38 HDFs progressing towards senescence.
Since AS-miR-24 elevated p16 levels in both HeLa and WI-38
cells, and p16 functions as a potent inhibitor of cell proliferation in
the presence of an intact Rb pathway (such as in WI-38 cells), we
hypothesized that AS-miR-24 might elicit growth arrest and possibly
enhance the senescent phenotype of HDFs. These possibilities were
tested in WI-38 cells following AS-miR-24 transfection. Forty-eight
hr after transfection, we measured
3H-thymidine incorporation;
against our prediction, WI-38 cells in the AS-miR-24 transfection
group showed elevated DNA synthesis (Supplemental Fig. S3A).
Moreover, following an extended transfection protocol (cells were
sequentially transfected with AS-miR-24 for two weeks), the number
of cells staining positive for the senescence-associated (SA) b-
galactosidase activity (a marker of replicative senescence) did not
increase but instead decreased in the AS-miR-24 treatment group
(Supplemental Fig. S3B). Conversely, overexpression of miR-24
(which reduced p16 levels, as shown in Fig. 4B), did not trigger the
expected increase in proliferation, but instead reduced it (Supple-
mental Fig. S4A); similar findings were obtained using cervical
carcinoma cells (HeLa) and liver carcinoma cells (HepG2, not
shown). Furthermore, extended overexpression of miR-24 after a
two-week period of sequential transfections, increased SA-b-
galactosidase activity (Supplemental Fig. S4B), instead of decreasing
it, as anticipated. Delivery of Pre-miR-24 by using a lentiviral vector
also failed to reduce the senescence phenotype (not shown).
The absence of a senescent phenotype was disappointing, but it
illustrated critical aspects of the analysis and interpretation of
microRNA data. A single miRNA can regulate many transcripts,
possibly hundreds or thousands of transcripts. Thus, to expect a
strictly linear sequence of events [single microRNA change R
single altered protein R single phenotypic alteration] would be to
disregard the exquisite complexity of miRNA regulatory networks.
In the case of miRNA networks influencing cellular senescence,
three observations can be made. First, miR-24 is predicted to bind
to transcripts encoding proliferative proteins such as H-Ras (not
shown), proteins acting downstream of p16, like CDK6 (Supple-
mental Fig. S5) and E2F2 (not shown), and also p14ARF, which
shares much of the p16 mRNA sequence and is thus similarly
inhibited by miR-24 (Supplemental Fig. S6). A list of additional
targets of miR-24 is available from the authors. Second, p16
protein levels increase dramatically in S cells (by .40 fold, Fig. 1B),
but much of this elevation is elicited by heightened p16 mRNA
levels (Fig. 1A). The translational influence of modulating miR-24
levels only achieves ,3- to 5-fold differences in p16 abundance
(Fig. 4), far from the magnitude of change observed with
replicative senescence. Thus, the relatively modest changes in
p16 mediated by altering miR-24 levels are likely insufficient to
recapitulate the influence of p16 changes occurring during
senescence. Third, the process of replicative senescence is
accompanied by many senescence-associated changes in the levels
of numerous other miRNA, as shown in Fig. 2A. The influence of
these miRNAs upon replicative senescence, as well as the influence
of miR-24 upon additional targets which might impact on the
senescence/proliferative phenotype of WI-38, both await further
analysis. Instead, we set out to gain molecular insight into the
regulation of p16 expression levels by miR-24. To this end, we
employed another cell system that was amenable to interventions
requiring large amounts of cells, as described below.
Reduced p16 Expression by Ectopic Overexpression of
miR-24
We used HeLa cells to investigate how miR-24 regulated p16
expression. Using HeLa cells, polysome fractionation followed by
RT-qPCR analysis revealed that, similarly to WI-38 HDFs, miR-
24 was localized predominantly in fractions 1 and 2, and hence
dissociated from the translational apparatus (Fig. 5A). However, a
fraction of miR-24 was also present in association with translating
polyribosomes, since puromycin treatment shifted the miR-24
distribution towards lighter gradient fractions (Fig, 5A,B). The
significance of this distribution pattern and the precise location
within sucrose gradients wherein miRNAs exert their translation
inhibitory function remain to be elucidated. First, we tested the
effect of overexpressing miR-24 in HeLa cells by transfecting pre-
miR-24 and monitoring its abundance in cells by RT-qPCR
(Fig. 5C). Evidence that miR-24 interacted with the p16 mRNA
was then obtained using a method previously reported to study the
functional effects of miRNAs on target mRNAs [29]. HeLa cells
were co-transfected with a plasmid that expressed HA-Ago1 and
Figure 4. Modulation of miR-24 alters p16 levels in WI-38 HDFs.
Late-passage WI-38 cells (pdl 51) were transfected with pre-miR-24 or
Ctrl. siRNA (100 nM) and 48 hr later (A) RT-qPCR was used to measure
the levels of p16 mRNA (normalized to GAPDH mRNA levels, left) and
the levels of miR-24 (normalized to 18S rRNA levels, right), and (B) the
levels of p16 and loading control a-Tubulin were monitored by Western
blotting, and quantified (%) by densitometry. Early-passage (pdl 20) WI-
38 cells were transfected with AS-miR-24 or Ctrl. siRNA (100 nM) and
48 hr later (C) RT-qPCR was used to measure the levels of p16 mRNA
(normalized to GAPDH mRNA levels, left) and the levels of miR-24
(normalized to 18S rRNA levels, right), and (D) p16 and loading control
a-Tubulin levels were assessed by Western blotting, and quantified by
densitometry. (E) p16 mRNA levels in sucrose gradients were calculated
as described for Fig. 1C. (A) and (C) show the means+SD from 3
independent experiments.
doi:10.1371/journal.pone.0001864.g004
miR-24 Blocks p16 Translation
PLoS ONE | www.plosone.org 4 March 2008 | Volume 3 | Issue 3 | e1864Figure 5. miR-24 associates with p16 mRNA and with actively translating polysomes in HeLa cells. (A) Cells were left untreated (Untr.)o r
treated with puromycin (Puro., 200 mM, 1 hr); cytoplasmic lysates were prepared and fractionated through sucrose gradients. Top, representative miR-
24 levels in each fraction, visualized after RT-PCR (30 cycles) and electrophoresis (1.5% agarose). Bottom, miR-24 levels in each fraction, quantified by
RT-qPCR analysis and represented as % of the total miR-24 (semilogarithmic scale). (B) Representative gradient profiles. (C) By 48 hr after transfection
of pre-miR-24 or control (Ctrl.) siRNA (100 nM), miR-24 and U6 snRNA levels were visualized on agarose gels (left), quantified by RT-qPCR, and
normalized to 5S (right). Data (means+SD) represent the fold differences in miR-24 levels between the transfection groups. (D) HeLa cells were
transfected with a plasmid expressing either pTRESNeo (V) or pIRESNeo-HA-Ago1 (HA-Ago1); the specific IP of HA-Ago1 was assessed by Western blot
analysis of the IP reaction products. Forty-eight hr after transfection of HeLa cells with plasmid (V or HA-Ago1) and either control (siRNA) or pre-miR-
24 RNA, RT-qPCR analysis was used to test the association of p16 mRNA with the RISC complex in the V and HA-Ago1 groups after HA IP. Graphs
show the means+SD from 3 independent experiments.
doi:10.1371/journal.pone.0001864.g005
miR-24 Blocks p16 Translation
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which HA-Ago1 was immunoprecipitated (Materials and Meth-
ods). RT-qPCR analysis of the IP material revealed that the
presence of p16 mRNA in the HA-Ago1 IP increased markedly
after overexpressing miR-24 (Fig. 5D). Similarly, other miR-24
targets such as the CDK6 mRNA showed increased association
with HA-Ago1 after overepressing miR-24, while CDK6 mRNA
levels remained unchanged (Supplemental Fig. S5).
Overexpression of miR-24 in HeLa cells did not significantly
alter the relative distribution of miR-24 on polysome gradients
(Fig. 6A), nor did it influence the levels of p16 mRNA in the Ctrl.
siRNA and pre-miR-24 transfection groups (Fig. 6B). However,
p16 protein levels were markedly lower in the pre-miR-24 group
relative to the control group (Fig. 6C). Since the p16 mRNA
distribution profiles in polysome gradients from control and pre-
miR-24 transfection groups were largely overlapping (Fig. 6D), the
Figure 6. Increasing miR-24 reduces p16 levels in HeLa cells. (A) HeLa cells were transfected with either Ctrl. siRNA or pre-miR-24 (100 nM)
and 48 hr later cytoplasmic lysates were prepared and fractionated through sucrose gradients. The levels of miR-24 were then measured by RT-qPCR
in each of the fractions (Materials and Methods) and shown as relative (fold) miR-24 levels in the pre-miR-24 transfection group relative to the levelsi n
the Ctrl. siRNA transfection group (left) and also as a percentage of the total miR-24 in each of the two transfection groups (right). (B) HeLa cells were
transfected and processed as described in panel (A) except that the comparisons were made between populations transfected with AS-miR-24 and
Ctrl. siRNA. The levels of mRNAs encoding p16 and housekeeping controls GAPDH (for normalization) and SDHA were calculated by RT-qPCR and
represented (means+SD from 3 independent experiments) as fold differences relative to control transfected cells. (C) Representative Western blot
analysis of p16 (and loading control a-Tubulin) levels in each transfection group. p16 protein signals were measured by densitometry and
represented as a percent of the p16 levels in the control transfection group. (D) Representative distribution of p16 and GAPDH mRNAs on polysome
gradients, calculated and shown as explained for Fig. 1C.
doi:10.1371/journal.pone.0001864.g006
miR-24 Blocks p16 Translation
PLoS ONE | www.plosone.org 6 March 2008 | Volume 3 | Issue 3 | e1864reduced p16 protein levels did not appear to result from lower p16
translational initiation. Instead, our collective results suggest that
miR-24 overexpression reduces the elongation, rather than the
initiation of p16 translation.
Enhanced p16 Expression After Reducing miR-24
Function
Further analysis of the influence of miR-24 upon the translation
of p16 was conducted by introducing an transcript antisense (AS)
to miR-24. By 48 h after transfection of 100 nM AS-miR-24, the
levels of miR-24 were markedly reduced, suggesting that the RNA
duplex promoted the degradation of miR-24 (Fig. 7A). AS-miR-
24-overexpressing HeLa cells displayed modest increases in p16
mRNA levels compared with control (Ctrl.) siRNA-transfected
populations (Fig. 7A), although the p16 mRNA half-life (.12 h)
appeared unaffected by the reduced miR-24 levels (not shown). By
contrast, p16 expression increased .threefold (Fig. 7B). Despite its
reduced abundance, the remaining miR-24 showed a comparable
polysome gradient distribution between the two transfection
groups (Fig. 7C). The translational status of p16 mRNA was
tested by comparing its relative distribution in sucrose gradients
prepared from both transfection groups. As shown, AS-miR-24-
expressing cells exhibited a moderate but distinct shift towards the
actively translating fractions, indicating that p16 mRNA associat-
ed with larger polysomes in these cells (Fig. 7D), and suggesting
that translational initiation was enhanced after miR-24 levels were
reduced. Together with plausible changes in the rates of
translational elongation, as discussed above (Fig. 4E), AS-miR-24
caused a marked elevation in p16 expression levels (Fig. 7B).
Importantly, the notion that p16 translation was comparatively
higher was supported by measuring de novo p16 biosynthesis after a
brief (15-min long) incubation period with
35S-methionine and
35S-cysteine, immediately followed by immunoprecipitation (IP)
reactions using anti-p16 or control IgG antibodies. The radiola-
beled signals revealed .twofold higher nascent p16 translation in
the AS-miR-24 transfection group (Fig. 7E), while the nascent
translation of a control housekeeping protein (GAPDH) was
unaffected. These findings indicated that miR-24 contributed to
lowering the translation rate of p16, and suggested that a reduction
in translational initiation also contributed to this inhibitory effect.
It is formally possible that the changes in miR-24 levels and
function (by pre- or AS-miR-24 molecules) do not affect p16
translation and instead influence the stability of p16 protein. This
is a less plausible mode of action for miR-24, given the paucity of
evidence that p16 levels are controlled through regulated
proteolysis. In a single study, p16 degradation was found to be
governed by the ubiquitin-proteasome system in a density-
dependent manner [30]; in this regard, cell density was virtually
the same among the HeLa and WI-38 transfection groups. Using
cycloheximide, we did not detect any influence of miR-24 on p16
protein half-life (not shown).
Heterologous Reporter Analysis of miR-24 Influence on
p16 Expression
The influence of AS-miR-24 on p16 translation was further
tested by employing a heterologous reporter system that studies the
expression of d2EGFP (Clontech, Materials and Methods), a short-
lived variant of EGFP which is uniquely suited for this analysis.
The effect of sequences within the p16 mRNA on d2EGFP protein
expression was studied by using a previously reported tTA-
regulated construct [17] which expresses a chimeric mRNA
comprising the EGFP coding region and the entire p16 CR and
39UTR (EGFP-p16 mRNA). HeLa Tet-off cells were transfected
transiently with a vector to express EGFP mRNA or with one of
four vectors to express EGFP-p16 mRNA bearing intact miR-24
target CR and 39UTR sequences, mutated CR (mCR), mutated
39UTR (m39) or both mutations (mCR+m39), as shown in Fig. 8
(schematic). By 48 hr after transfection, the expression of both
EGFP and EGFP-p16 mRNAs remained unchanged as a function
of AS-miR-24 (Supplemental Fig. S7). By contrast, the levels of
EGFP protein expressed from each transcript was markedly
different: EGFP protein expressed from the control EGFP reporter
was unchanged between the control and AS-miR-24 transfection
groups, while EGFP expressed from the EGFP-p16 chimeric
mRNA was significantly higher (,11-fold) in the AS-miR-24
group than in the control group. Mutation of the p16 CR site
predicted to be targeted by miR-24 (mCR) or both the CR and
39UTR sites (mCR+m39) effectively abrogated this induction in
EGFP expression, while mutation of only the 39UTR (m39) had a
partial effect (,3-fold induction), as shown in Fig. 8. These results
strongly support the view that miR-24 influences p16 expression
through the predicted CR and 39UTR target sites.
miR-24 Appears to Suppress the Initiation and Elongation
of p16 Translation
Collectively, our results indicate that miR-24 suppresses p16
translation in a cancer cell model (HeLa) and in a model of
replicative senescence (WI-38 HDFs). The finding that miR-24
suppresses p16 translation but does not appear to influence p16
mRNA levels agrees with growing evidence that mammalian
miRNAs more commonly suppress protein biosynthesis than they
promote target mRNA degradation. The evidence presented here
provides mechanistic support for the notion that miR-24
suppresses p16 production by inhibiting both the initiation and
elongation of p16 translation.
Supporting the possibility that p16 translation initiation was
suppressed by miR-24 are data showing that a reduction in miR-
24 function by AS-miR-24 caused a modest shift in p16 mRNA
towards heavier polysomes (Fig. 7D). This rightward shift in
polysome size indicates that, on average, individual p16 mRNA
molecules were associated with a higher number of ribosomes and
were thus expected to be translated more actively. The miRNA-
mediated silencing of gene expression has been linked to the
recruitment of target mRNAs to P-bodies; these foci are implicated
in mRNA degradation [31], and also in translational repression as
they lack translational constituents and contain protein compo-
nents of RISC (such as Ago1) that interact directly with miRNAs
[32]. The suppression of translation by miRNA/RISC has been
linked to the presence of the eIF6 anti-association factor (which
prevents the assembly of the 80S ribosome) [33]. It remains to be
established whether miRNA/RISC also suppresses translational
initiation by causing the mRNA to exit translation, by recruiting
the mRNA to P-bodies, or by promoting the association of RBPs
that transport the mRNA to P-bodies [19].
The notion that miR-24 might also suppress the elongation phase
of p16 translation is supported by our results that ectopic miR-24
overexpression markedly reduced p16 protein levels without
changing p16 mRNA levels or distribution on polysome gradients
(Fig. 6D). This mechanism of miRNA action is reminiscent of that
described for the C. elegans miRNA lin-4, which silenced lin-14 and
lin-28 mRNAs without changing their polysomal distribution
[34,35]. Overexpression of miR-24 elevated its abundance in all of
the heavy polysome fractions (Fig. 6A), a finding that agreed with
miR-24’s suppression of the elongation phase of mature, heavy
polysomes. By contrast, downregulation of miR-24 (Fig. 7A)
preferentially reduced miR-24 abundance in non-polysomal
gradient fractions (Fig. 7C); this distribution pattern could
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PLoS ONE | www.plosone.org 7 March 2008 | Volume 3 | Issue 3 | e1864Figure 7. Lowering miR-24 increases p16 levels in HeLa cells. (A) Cells were transfected with either a control (Ctrl.) siRNA or antisense (AS)
miR-24 (100 nM) and the levels of mRNAs encoding p16, and controls GAPDH (for normalization) and SDHA were calculated by RT-qPCR and
represented as the means+SD from 3 independent experiments; the levels of miR-24 and U6 RNA were also measured. (B) Representative Western
blot analysis of p16 (and loading control a-Tubulin) levels in each transfection group. p16 signals were measured by densitometry and represented as
% p16 levels relative to the control transfection group. (C) The levels of miR-24 were measured by RT-qPCR in each of the fractions (Materials and
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and have a lesser influence on the elongation of formed polysomes,
although this hypothesis awaits experimental analysis. The
miRNA-mediated suppression of elongation and termination of
translation are less well characterized, although recent studies
indicate that miRNAs can block elongation of translating polysomes
by causing them to cease translation and ‘drop-off’ [24]. Moreover,
miRNA/RISC complexes could influence all steps in translation
(initiation, elongation, termination) in ways that the distribution on
polysome profiles could remained unchanged, although it must be
noted that if only elongation or termination were inhibited, the
mRNAs would be expected to form larger polysomes.
Concluding remarks
Evidence is mounting that an integrated set of mechanisms
controls p16 levels. Transcriptionally, p16 expression is dictated by
changes in chromatin and transcription factors, and posttranscrip-
tionally, it is shaped through changes in mRNA stability and
translation. Future study of the physical and functional connec-
tions among posttranscriptional trans acting factors (miRNAs and
RBPs) operating upon the p16 mRNA and other transcripts
promises to be a particularly exciting endeavor. For instance, the
co-transcriptional loading of trans factors can link transcriptional
events with subsequent splicing, transport, stability, and
translation [36], trans factors are implicated in mRNA stability
and translation decisions made at P-bodies and other cytoplasmic
structures [37,38], and are anticipated to interact richly upon the
target mRNA [39]. For genes playing pivotal cellular functions,
such as p16 and other tumor suppressors and senescence-
associated proteins, such multi-leveled, complex regulatory
networks are expected. The resulting system of checks and
balances will ensure the precise abundance, location, and timing
of protein production.
Materials and Methods
Cell Culture and Transfections
Human cervical carcinoma HeLa cells were cultured as
described [40]. Early-passage (,20–25 pdl) and late-passage
(,50–55 pdl) human WI-38 human diploid fibroblasts (HDFs,
Coriell Cell Repositories) were cultured as described [17].
Synthetic 29O-methyl antisense (AS-miR-24) or pre-miR-24
oligonucleotides (Ambion) were transfected at a final concentra-
tion of 100 nM; oligonucleotides and plasmids were transfected
with Lipofectamine 2000 (Invitrogen). Plasmids pTRESNeo (V,
from Clontech) or pIRESNeo-HA-Ago1 (HA-Ago1, from Ad-
dgene) were transfected (2 mg per plate) to study the association of
miR-24 with mRNAs in the RISC complex.
HeLa Tet-off cells (Clontech) were transfected with the parent
reporter vector pTRE-d2EGFP (pEGFP), or with pTRE-d2EGFP-
p16(CR+39UTR) (pEGFP-p16), which comprises the p16 CR and
39UTR wild-type [17] or mutated sequences of the predicted CR
and/or 39UTR miR-24 sites. The reporter vectors used in Fig. 8
are as follows: pEGFP – parent reporter vector pTRE-d2EGFP;
pEGFP-p16 – plasmid pTRE-d2EGFP-p16(CR+39UTR), which
comprises the wt p16 CR and 39UTR [17]; pEGFP-p16(mCR) –
plasmid pTRE-d2EGFP-p16(CR+39UTR), in which the predicted
p16 CR miR-24 site was mutated (m) from TCCTGGCTGAG-
GAGCTGGGCCA to TCCTGGCTGAGGAGCTGCGA CA
by site-directed mutagenesis; pEGFP-p16(m39) – plasmid pTRE-
d2EGFP-p16(CR+39UTR), in which the predicted p16 39UTR
miR-24 site was mutated (m) from GTTACTGGCTTCTCTT-
GAGTCA to GTTACTGGCTTCTCTTGCGGCA by site-
directed mutagenesis; pEGFP-p16(mCR+m39) – plasmid pTRE-
d2EGFP-p16(CR+39UTR), in which both of the predicted miR-
24 target sites on the p16 CR and 39UTR were mutated as
indicated above. Briefly, HeLa tet-off cells were contransfected
with 0.5 mg of plasmid pTRE-d2EGFP (with or without the
binding site for miR-24) along with either Ctrl. siRNA or AS-miR-
24, using Lipofectamine 2000; 48 hr later, cells were harvested in
RIPA buffer and samples subjected to SDS-PAGE and Western
blot analysis to detect EGFP and a-Tubulin. Transcription was not
shut off at any point during the analysis.
Prediction of p16 mRNA as a target of miR-24
The p16 mRNA was predicted to be the target of miR-24 at two
sites (CR and 39UTR) after performing computational analyses
using two different programs, Miranda and RNA22. Using
RNA22 (http://cbcsrv.watson.ibm.com/rna22.html) and the se-
quences of p16INK4A and miR-24, the program returned the two
hits shown in Fig. 3A (in the CR and the 39UTR) and in
Supplemental Figure S7. The default stringency settings were
used: maximum number of allowed UN-base paired bases=0 in
seed/nucleus of 7 nucleotides, and minimum number of paired-up
Methods) and shown as relative miR-24 levels in the AS-miR-24 transfection group relative to the levels in the Ctrl. siRNA transfection group (left) and
also as a percentage of the total miR-24 in each of the two transfection groups (right). Note that the abundance of miR-24 was preferentially reduced
in fractions 1 and 2 (left), but the remaining miR-24 was found distributed among all of the fractions of the polysome gradient (right). Data are
representative from three independent experiments yielding similar results. (D) The levels of p16 and control GAPDH mRNAs on polysome gradients
were measured and represented as explained in the legend of Fig. 1C. (E) Nascent translation of p16 or (control) GAPDH was monitored following
incubation of cells with L-[
35S]methionine and L-[
35S]cysteine for 15 min; after immunoprecipitation (IP) using either anti-p16 (left) or anti-GAPDH
(right) antibodies along with control IgG, the incorporation of radiolabeled amino acids into newly synthesized p16 and GAPDH polypeptides was
visualized after SDS-PAGE and quantified using a PhosphorImager; the % change in p16 nascent translation is shown.
doi:10.1371/journal.pone.0001864.g007
Figure 8. Analysis of p16 predicted sites of miR-24 association
using a heterologous reporter. Schematic (left) and names (center)
of the EGFP and chimeric EGFP-p16 reporter plasmids tested (Materials
and Methods). By 48 hr after co-transfection of HeLa Tet-off cells with
Ctrl. siRNA or AS-miR-24, along with the plasmids indicated, the levels of
EGFP expressed from each reporter vector was assessed; shown are
representative Western blotting signals and quantification (Fold, AS-
miR-24 vs. Ctrl. siRNA) of EGFP reporter levels in each transfection group
after normalization to a-tubulin signals.
doi:10.1371/journal.pone.0001864.g008
miR-24 Blocks p16 Translation
PLoS ONE | www.plosone.org 9 March 2008 | Volume 3 | Issue 3 | e1864bases in heteroduplex=14; maximum folding energy for hetero-
duplex (Kcal/mol=225).
Polyribosome Fractionation
Cells were incubated with cycloheximide (100 mg/ml, 15 min)
and cytoplasmic lysates (500 ml) were fractionated by centrifuga-
tion through 10–50% linear sucrose gradients and divided into 10
fractions for analysis, as described [40].
RNA Isolation and analysis
Total RNA was isolated with the Trizol reagent (Invitrogen).
Conventional and quantitative (or real-time, q) RT-PCR were done
as described [40]. Briefly, 1 mgoftotalRNAor50%ofRNAisolated
from each gradient fraction were reverse transcribed using random
hexamers and SSII RT (Invitrogen); the resulting cDNA was
amplified by PCR using gene-specific primer pairs; mature miR-24,
5S rRNA, and U6 snRNA were quantified using mirVana miRNA
primer sets and qRT-PCR miRNA detection kit (Ambion).
MicroRNA microarray analysis was performed by using the
miRCURY
TM LNA Array (version 8.1) microRNA Profile Service
from Exiqon (Vedbaek, Denmark). Total RNA (10 mg) prepared
from Y (pdl 25) and S (pdl 54) was used. Three independently
prepared sample sets were used for microarray analysis; miRNAs
were considered to be differentially expressed when they were
upregulated or downregulated in at least two experiments.
Western Blotting
Proteins were resolved by 14% SDS-PAGE and transferred to
PVDF membranes (Invitrogen). Primary antibodies recognized
p16, a-tubulin, EGFP (Santa Cruz Biotech.) or b-actin (Abcam);
after secondary antibody incubations, protein bands were detected
by ECL-plus (Amersham).
Analysis of Nascent Protein
De novo p16 or GAPDH protein synthesis was measured by
incubating HeLa cells with 1 mCi L-[
35S]methionine and L-
[
35S]cysteine (Easy Tag EXPRESS, NEN/PerkinElmer) for
15 min, followed by lysis with RIPA buffer and IP with 10 mg
anti-p16 or anti-GAPDH antibodies (Santa Cruz Biotech.); IgG
was used in control IP reactions. Beads were washed in RIPA
buffer and the IP material was resolved by 14% SDS-PAGE,
transferred onto PVDF membranes, and visualized and quantified
using a PhosphorImager.
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